| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Suavioside A; Suavioside A | CFN96655 | 133740-37-1 | C26H44O8 = 484.63 | 5mg | QQ客服：215959384 |
| Spiratisanin C; Spiratisanin C | CFN96667 | 1902173-22-1 | C29H40O3 = 436.63 | 5mg | QQ客服：2159513211 |
| Spiratisanin B; Spiratisanin B | CFN96668 | 1902173-19-6 | C29H40O3 = 436.63 | 5mg | QQ客服：3257982914 |
| Spiratisanin A; Spiratisanin A | CFN96669 | 1902173-16-3 | C29H40O3 = 436.63 | 5mg | QQ客服：3257982914 |
| Siegeskaurolic acid; Siegeskaurolic acid | CFN96674 | 52645-97-3 | C20H32O3 = 320.47 | 5mg | QQ客服：2056216494 |
| 13-脱氧-10-O-乙基-8-羟基延命素; Serrin A | CFN96677 | 845959-98-0 | C22H30O6 = 390.47 | 5mg | QQ客服：1457312923 |
| 半枝莲碱 Z ; Scutebarbatine Z | CFN96683 | 1312716-28-1 | C26H33NO5 = 439.55 | 5mg | QQ客服：215959384 |
| 半枝莲碱 Y; Scutebarbatine Y | CFN96686 | 1312716-27-0 | C33H35NO7 = 557.64 | 5mg | QQ客服：3257982914 |
| Sahandol; Sahandol | CFN96688 | 1452398-07-0 | C20H24O2 = 296.41 | 5mg | QQ客服：2159513211 |
| 香紫苏内酯 ; Sclareolide | CFN96690 | 564-20-5 | C16H26O2 = 250.38 | 20mg | QQ客服：1413575084 |
| 半枝莲碱 X; Scutebarbatine X | CFN96691 | 1312716-26-9 | C34H38N2O10 = 634.68 | 5mg | QQ客服：3257982914 |
| Norcaesalpinin E ; Norcaesalpinin E | CFN96700 | 854038-96-3 | C21H28O6 = 376.44 | 5mg | QQ客服：1413575084 |
| 香紫苏二醇 ; Sclareol glycol | CFN96701 | 55881-96-4 | C16H30O2 = 254.41 | 5mg | QQ客服：3257982914 |
| 半枝莲碱 W ; Scutebarbatine W | CFN96705 | 1312716-25-8 | C33H37NO8 = 575.65 | 5mg | QQ客服：215959384 |
| Hebeirubescensin H; Hebeirubescensin H | CFN96853 | 887333-30-4 | C20H28O7 = 380.43 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)